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Abstract Capsaicin was used as a bio-reductant for the
reduction of silver nitrate to form silver nanoparticles. The
formation of the silver nanoparticles was initially con-
firmed by color change and Tyndall effect of light scat-
tering. It was characterized with UV–visible spectroscopy,
FTIR and TEM. Hemagglutination (H) test and H-inhibi-
tion assay were performed in the presence of AgNPs–
capsaicin conjugates. The silver colloid solution after
complete reduction turned into pale gray color. The char-
acteristic surface plasmon resonance of silver nanoparticles
(SNPs) was observed at 450 nm. Time taken for complete
bio-reduction of silver nitrate and capping was found to be
16 hours. The amount of capsaicin required to reduce
20 ml of 1 mM silver nitrate solution was found to be
40 lg approximately. The FTIR results confirmed the
capping of capsaicin on the silver metal. The particle size
was within the range of 20–30 nm. The hemagglutination
and H-inhibition test was negative for all the blood groups.
The capsaicin-capped silver nanoparticles were compatible
with blood cells in hemagglutination test implying bio-
compatibility as future therapeutic drug.
Keywords Capsaicin  Silver nanoparticles (SNPs) 
AgNO3  Bio-reductant  Biocompatibility 
Hemagglutination
Introduction
Nanotechnology has a massive impact on therapeutic
drugs. It significantly improves the performance of drugs in
terms of efficacy and safety. Wide range of nano materials
can be designed with surface modification to tag variety of
chemical, molecular and biological entities (Kumari et al.
2012; Baimark 2012). Capping agents that bind to the
nanoparticles surface will improve stability, water solu-
bility, biocompatibility, specificity and prevent aggregation
(Sing et al. 2009).
Silver has been used for medicinal purpose in the field
of health care from ancient period (Priyaragini et al.
2013). The reduction of silver nitrate to silver nanoparti-
cles was described by (Jin et al. 2001). ‘‘Green synthesis’’
of nanoparticles is a beneficial method that makes use of
non-toxic reagents. Silver nanoparticles have tremendous
scope, because of their important applications in antimi-
crobial, catalysis and surface-enhanced Raman scattering
(Li et al. 2006; Chen et al. 2005; Setua et al. 2007).
Silver-based drugs have proved as antimicrobial agents.
The rapid breakdown of silver nanoparticles releases ionic
silver that inactivates vital bacterial enzymes by inter-
acting with essential thiol groups. Silver ions can inhibit
bacterial DNA replication, damage bacterial cytoplasmic
membranes, deplete the levels of intracellular adenosine
triphosphate (ATP) and finally cause cell death (Feng
et al. 2000).
Plant-derived drugs have served as the base for an
enormous fraction of the current pharmacopoeia (Kingston
and Newman 2002). Plant-based therapeutic molecules as
drugs have limitations due to reduced solubility, perme-
ability and bioavailability (Kumari et al. 2012). In spite of
the challenges, the following natural products like arte-
misinin, curcumin, triptolide and capsaicin have been
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broadly studied and have entered into clinical trials (Cor-
son and Crews 2007). In chemotherapy, plant origin drugs
cause damage equally to both normal and malignant cells.
By carefully designing the nanocarriers, natural product
formulations can be targeted to specific cells (Sahoo and
Labhasetwar 2003).
Capsaicin (8-Methyl-N-vanillyl-trans-6-nonenamide) is
an active component of capsicum species. It is responsible
for the characteristic pungent smell. It has several potential
applications as anticarcinogenic [14] antioxidant (Rosa
et al. 2002), suppressor of fat accumulation (Yoshioka et al.
1999), anti-inflammatory (Fraenkel et al. 2004; Fernando
Spiller et al. 2008) and as antimicrobial agent (Kurita et al.
2002; Zeyrek and Oguz 2005).
Pure capsaicin is a hydrophobic, colorless, odorless, and
crystalline to waxy compound. It has the chemical formula
C18H27NO3, with a molar mass of 305.40 g/mol
(‘‘ChemSpider’’). The structure of the capsaicin molecule
can be divided into three distinct regions, [A] as a vanillyl
group, [B] an amide bond and [C]a fatty acid chain (Fig. 1)
(Hopur2 2009). Due to the presence of the hydrophobic
side chain, capsaicin is lipophilic and, therefore, highly
soluble in fat, oil, and alcohol (Reyes-Escogido et al.
2011). It has poor bioavailability due to its hydrophobic
nature like many other natural phytomedicines which is a
major limitation in drug delivery. Therefore, in the present
study, the capping of capsaicin on AgNPs by the direct
reduction of silver nitrate in the aqueous phase, without the
use of any other reducing agents was undertaken with the
aim of developing a potential therapeutic drug.
Materials and methods
Synthesis of silver nanoparticles and UV–vis
spectroscopy studies
Capsaicin (8-methyl-N-vanillyl-trans-6-nonenamide) was
purchased from Sigma Chemical Co, St. Louis, MO, USA.
The silver nitrate was purchased from Qualigens, Mumbai.
Glasswares were rinsed with deionised water before start-
ing the synthesis. 20 ml of 1 mM AgNO3 was rapidly
stirred at 60 C to which 100 ll of 1 mg/ml concentrated
solution of capsaicin was added. Silver nanoparticles
gradually formed as the capsaicin reduces and binds to the
surface of silver nanoparticles (SNPs). Further heating was
stopped when the reaction mixture turned purple. The
presence of colloidal nanoparticles in the solution was
detected by passing laser beam. The bio-reduction was
monitored at different time intervals of 30 min, 1, 2, 16 and
24 h by color change and UV spectroscopy measurement.
Kinetics
UV–vis spectroscopy measurements of the silver nitrate
solution, capsaicin and capsaicin-capped silver nanoparti-
cles were carried out on a UV–vis spectrophotometer UV-
2450 (Shimadzu). The kinetics of bio-reduction of silver
nano particles at different time intervals was recorded. The
spectra from 200 to 800 nm were recorded for the syn-
thesized silver nanoparticles—pellet and remaining cap-
saicin in the supernatant after centrifugation.
Fourier transforms infrared (FTIR) spectroscopy
measurements
After complete reduction, the colloidal silver nanoparticles
were centrifuged at 12,000 rpm for 10 min to isolate the
silver nanoparticles. The silver nanoparticles pellet
obtained after centrifugation were resuspended in deion-
ised water and again centrifuged to remove the traces of
free capsaicin present in the solution prior to FTIR ana-
lysis. FTIR spectrum was taken to assess functional groups
and the involvement of possible capping of capsaicin on
silver nanoparticles was carried out on a Perkin-Elmer
FTIR spectrum one spectrophotometer.
TEM measurements
TEM samples of the silver nanoparticles were prepared by
placing a drop over carbon-coated copper grids and
allowing the solvent to evaporate. TEM measurements
were performed on a JEOL model 1200EX instrument
operated at an accelerating voltage between 80 and
200 kV.
Hemagglutination test
This test was performed in the microtiter plate. To each
well, 50 ll of PBS was added. The following solutions
were added in the given order. In column 1 (A–F) 50 ll of
PBS that serves as control without any treatment was
added. To columns 2, 3 and 4 50 ll of Anti-A, Anti-B and
Fig. 1 Chemical structure of capsaicin
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Anti-D were added, respectively. To the column 5, 50 ll of
PHA (Himedia, Mumbai) was added. In column 6 of A, C
and F 50 ll of capsaicin-capped silver nanoparticles was
added, mixed well and 50 ll transferred to the next well on
its right. Repeated mixing and transfer of 50 ll down the
length of the plate up to column 9 was done; final 50 ll
from the last well was discarded into a bleach solution.
Agglutination inhibition test was performed by mixing the
anti-A, B and D with nanoparticles in columns 10–12. To
each well, 50 ll of 0.5 % red blood cells was added. It was
incubated at room temperature for 30–60 min. Negative
results appeared as dots in the center of round-bottomed
plates. Positive results formed a uniform reddish color
across the well.
Results
Synthesis and UV–vis spectroscopy studies
Silver nitrate solution mixed with capsaicin solution
showed no significant change in the UV–vis spectra at 0 h,
only the characteristic peak of capsaicin at 220 nm was
observed in the curve Fig. 2b and found to be 100 lg
calibrated using linear regression equation
(Y = 0.00919X - 0.0084) of capsaicin. As the time
increased decrease in the capsaicin peak at 220 nm, with an
emerging peak around 458 nm as well as a change in color
of the solution to pale gray color indicated the reduction of
silver nitrate to silver nanoparticles as shown in (Fig. 3a).
Absorption spectra of silver nanoparticles formed in the
reaction mixture had absorbance peak at 450 nm, arising
due to the excitation of surface plasmon vibrations in the
silver nanoparticles as seen in (Fig. 2d).
Kinetics
Time taken for complete bio-reduction of silver nitrate and
capping was found to be 16 h even after which the
reduction was stationary up to 24 h (Fig. 2d). The UV
spectrum of the nano pellet after centrifugation was devoid
of capsaicin peak (Fig. 2e). But free capsaicin peak was
found in the supernatant and measured about 60 lg
(Fig. 2f). The amount of capsaicin required to reduce
20 ml of 1 mM silver nitrate solution was found to be
40 lg approximately.
FTIR
FTIR measurements were carried out to identify the pos-
sible biomolecules in the capsaicin-reduced nanoparticles
and also the capping agents responsible for the stability of
the biogenic nanoparticles solution. FTIR spectrum of
capsaicin showed prominent absorption bands at 3,435,
2,932, 2,351, 1,637, 1,538, 14,437, 1,026 and 812 cm -1.
Capsaicin structure has an aromatic ring, a polar group and
a hydrophobic moiety (Fig. 4a). FTIR was done to interpret
the structural modifications that had occurred in capsaicin
upon formation of capsaicin-capped SNPs. We got con-
spicuous peaks around 3,447, 2,922, 2,352, 1,635, and a
peak around 1,025 cm -1 followed by not-so conspicuous
peaklets (Fig. 4b). The bands around 3,400 cm-1 are likely
due to the presence of residual water molecules or the
presence of OH group in capsaicin. The bands around
Fig. 2 Time dependent UV–vis spectra during the formation of capsaicin-capped silver nanoparticles
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2,750–3,000 cm-1 are likely to originate from carbonyl
C=O group present in the capsaicin. The bands around
1,600–1,750 cm-1 are likely due to the amide present in
capsaicin molecule and the presence of peaklets at the
lower wave numbers following it could also likely suggest
the presence of aromatic C=C, which is present in capsa-
icin molecule, and the disappearance of the peaklets at the
lower wavenumber region after the formation of SNPs
suggests the possible structural change of the aromatic
group. It is known that aromatic groups reduce Ag ions into
metallic NPs, which peak around 1,646 cm-1 which is
likely to be aliphatic (alkene) C=C and whose absorption is
converged with aromatic and amide absorption bands.
HR-TEM measurements
TEM measurements divulged that the resultant product
after 24 h was composed of nearly spherical AgNPs with
20–30 nm diameter (Fig. 3c).
Hemagglutination test
One of the main aims of the current study is to increase the
bioavailability of capsaicin for biological applications. The
hydrophobic capsaicin is now conjugated with SNPs which
is in water, hence becoming more available. The SNPs act
as carrier of drug capsaicin. Before utilizing the SNPs–
capsaicin conjugates for clinical application, it is compul-
sory to confirm their biocompatibility particularly with
human blood. Hence, we have performed hemagglutination
(H) and H-inhibition assay in the presence of SNPs–cap-
saicin conjugates. The test was conducted with A, B and O
blood groups. The tested blood groups showed positive
results to respective test antigens. The capsaicin-capped
silver nanoparticles showed negative results for the
screened blood groups. But ‘‘O’’ positive blood group
showed light agglutination when compared to ‘‘A’’ and
‘‘B’’ blood groups. The hemagglutination inhibition test
was negative for all the blood groups. The assay result
Fig. 3 SNPs colloidal solution
(a), Tyndall effect (b) and TEM
image of capsaicin-capped
SNPs (c)
Fig. 4 FTIR transmittance spectra of capsaicin (a) and SNPs capped by capsaicin (b)
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confirms the compatibility of AgNPs–capsaicin conjugate
with normal blood cells, as RBC disruption was not
observed which would lead to H-agglutination (Fig. 5).
Discussion
In ayurvedic medicine, silver is used in petite amounts as a
tonic, elixir or rejuvenating agent. Currently, these are also
available in oral, injectable, and topical forms (Kishore
Madhukar Paknikar 2008). The ash of silver, also known as
Raupya Bhasma, is used to treat diseases and disorders like
pain, neuralgias, inflammation, anxiety, convulsions,
memory loss etc. (Nadeem et al. 1999; Hamilton et al.
1972). Moreover, nanosize of silver particle is possibly
responsible for improving the absorption of silver in brain
for the treatment of various pain and neurological condi-
tions, (Khanna et al. 1997; Wang et al. 2005; Chou et al.
2001). Capsaicin has been included in topical treatments
aimed at relief of different neuropathic pain syndromes
such as post-herpetic neuralgia, musculoskeletal pain,
diabetic neuropathy, osteoarthritis and rheumatoid arthritis
(Backonja et al. 2010; Tesfaye 2009; Watanabe et al. 1987;
Sawynok 2005; Derry et al. 2009). Hence our study on
capsaicin-capped silver nanoparticles has a huge impact in
the field of pharmacology as active drug for neurological
disorders.
In vitro studies in human skin showed that capsaicin
adsorption and biotransformation were found to be slow
and that most capsaicin remained unaffected, while a small
fraction was metabolized to vanillylamine and vanillyl acid
(Suresh and Srinivasan 2010; Chanda et al. 2008; Kawada
et al. 2008; Kawada and IwaiK 1985). The reason for this is
varying structures of the compounds, their fair aqueous
solubility, poor permeability and instability. The natural
products undergo fast oxidation under basic conditions and
first pass metabolism before reaching systemic circulation
(Haslam 1996; Anders 2002). Many pharmaceutical com-
panies synthesize several million compounds, but only a
few of those new chemical entities become leads for pre-
clinical development as a result of issues associated with
their solubility. Nanotechnology paves way for insoluble
compounds to be attached or encapsulated with highly
soluble nanoparticles, offering number of drugs entry into
clinical trials (McNeil 2005).
In this present study, capsaicin was found to be a
potential lipophilic alkaloid which reduced the silver
nitrate to silver nanoparticles. The absorption maxima of
silver nanoparticles were reported in the range of
400–500 nm (Prathna et al. 2011). The plasmon resonance
results of the present study were in accordance with pre-
vious reports of Vijayakumar et al. (2012) on Artemisia
nilagirica, indicating occurrence of a silver band at
340–400 nm. According to the finding of Geethalakshmi
and Sarada (2012), FTIR analysis of the silver nanoparti-
cles showed absorption peaks of reduced silver at 1,653.96
and 1,027.44 cm-1 for capsaicin-capped silver nanoparti-
cles. In FTIR, the shifting of peaks was observed which
may be attributed to the difference in capping and nature of
co-ordination with the metal surface of silver (Sing et al.
2009).
Protective role of capsaicin in the gastrointestinal tract
has produced controversial results and clearly indicate the
need for further clinical trials to better define effective
dosages (Holzer and Lippe 1988). Studies have been car-
ried to elucidate the pharmacokinetics of curcumin as it is
poorly absorbed from the gastrointestinal (GI) tract after
oral administration due to its low water solubility and low
stability in GI fluids. But nanoparticle formulations of
curcumin exhibited increased solubility in water compared
to free curcumin (Bisht et al. 2007). The orally adminis-
tered capsaicin was absorbed by the tissues and concen-
trated in the blood. About 24.4 % of administered
capsaicin was circulated to liver, kidney and intestine
through blood stream (Suresh and Srinivasan 2010). In our
study, the capsaicin-capped silver nanoparticles tested for
hemagglutination proved that they are highly biocompati-
ble with all three types of blood groups. Hence, the
Fig. 5 Hemagglutination and
hemagglutination inhibition test
for the capsaicin-capped silver
nanoparticles for ABO blood
groups. C Control, A Anti-A,





nanoparticles, and D?NP Anti-
D and nanoparticles
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capsaicin-capped silver nanoparticles would be a promis-
ing drug after high throughput in vivo screening.
Conclusion
Pure capsaicin lacks in bioavailability and permeability,
mainly due to its poor solubility in water. To improve the
bioavailability of capsaicin, it is conjugated to the surface
of metal nanoparticles. In the present study, we report the
binding of capsaicin to the surface of silver nanoparticles
(SNPs). The nanoparticles were characterized by FTIR and
TEM. The synthesized gold nanoparticles were found to be
20–30 nm in size. We found that capsaicin acts both as a
reducing and capping agent, stabilizing the silver solution
for 6 months. The synthesized SNPs were highly compat-
ible with ABO blood groups in hemagglutination test.
In vivo studies on the capsaicin-capped silver nanoparticles
can be carried out to test its efficacy in the topical
applications.
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